Actively Recruiting
Efficacy of Clonidine in Reducing Craving in Inpatients With Cocaine and Crack Use Disorder
Led by University of Sao Paulo General Hospital · Updated on 2026-02-24
36
Participants Needed
1
Research Sites
74 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a single-center, randomized intervention study in a volunteer population of patients with cocaine/crack use disorder to evaluate the pharmacological treatment of cocaine/crack craving, comparing the drug clonidine with the active placebo clonazepam.
CONDITIONS
Official Title
Efficacy of Clonidine in Reducing Craving in Inpatients With Cocaine and Crack Use Disorder
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients hospitalized in the adult Alcohol and Drugs ward of the Perdizes Institute at the Hospital das Clínicas, University of São Paulo Medical School
- Meet DSM-5 criteria for cocaine and/or crack use disorder
- Voluntarily seeking treatment
- Able to swallow pills
You will not qualify if you...
- Unable to read and/or understand the study questionnaires
- Diagnosed with benzodiazepine use disorder
- Diagnosed with opioid use disorder
- Diagnosed with alcohol use disorder
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Instituto Perdizes
São Paulo, São Paulo, Brazil, 05021-001
Actively Recruiting
Research Team
D
Dangela Lassi
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here